logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Vasomotor Menopausal Symptoms

    FiltersReset Filters
    7 results

    • bijuva

      (estradiol and progesterone)
      Mayne Pharma LLC
      Usage: The drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.

    • estradiol and norethindrone acetate

      (Estradiol and Norethindrone Acetate)
      Ingenus Pharmaceuticals, LLC
      Usage: Estradiol and norethindrone acetate tablets are indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, as well as for the prevention of postmenopausal osteoporosis in women at significant risk. Topical alternatives should be considered for certain conditions.

    • estrogel

      (estradiol)
      ASCEND Therapeutics US, LLC
      Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and moderate to severe vulvar and vaginal atrophy symptoms associated with menopause. For vulvar and vaginal atrophy, consider topical treatments first before prescribing this drug.

    • evamist

      (Estradiol)
      Padagis US LLC
      Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.

    • femring

      (estradiol acetate)
      Millicent US, Inc.
      Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy due to menopause.

    • fyavolv

      (Norethindrone Acetate and Ethinyl Estradiol)
      Lupin Pharmaceuticals, Inc.
      Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis. However, estrogen therapy should only be considered for osteoporosis in women at significant risk, with non-estrogen options preferred.

    • veozah

      (fezolinetant)
      Astellas Pharma US, Inc.
      Usage: VEOZAH® is indicated for treating moderate to severe vasomotor symptoms associated with menopause.